These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 17570334)
1. Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine. Li WW; Nemirovskiy O; Fountain S; Rodney Mathews W; Szekely-Klepser G Anal Biochem; 2007 Oct; 369(1):41-53. PubMed ID: 17570334 [TBL] [Abstract][Full Text] [Related]
2. Design and validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide in human urine: application as a biomarker of osteoarthritis. Nemirovskiy O; Li WW; Szekely-Klepser G Methods Mol Biol; 2010; 641():253-70. PubMed ID: 20407952 [TBL] [Abstract][Full Text] [Related]
3. Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo. Nemirovskiy OV; Dufield DR; Sunyer T; Aggarwal P; Welsch DJ; Mathews WR Anal Biochem; 2007 Feb; 361(1):93-101. PubMed ID: 17187753 [TBL] [Abstract][Full Text] [Related]
4. Online immunoaffinity liquid chromatography/tandem mass spectrometry determination of a type II collagen peptide biomarker in rat urine: Investigation of the impact of collision-induced dissociation fluctuation on peptide quantitation. Berna M; Schmalz C; Duffin K; Mitchell P; Chambers M; Ackermann B Anal Biochem; 2006 Sep; 356(2):235-43. PubMed ID: 16797470 [TBL] [Abstract][Full Text] [Related]
5. An immunoaffinity liquid chromatography-tandem mass spectrometry assay for detection of endogenous aggrecan fragments in biological fluids: Use as a biomarker for aggrecanase activity and cartilage degradation. Dufield DR; Nemirovskiy OV; Jennings MG; Tortorella MD; Malfait AM; Mathews WR Anal Biochem; 2010 Nov; 406(2):113-23. PubMed ID: 20603097 [TBL] [Abstract][Full Text] [Related]
6. Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples. van den Broek I; Sparidans RW; Schellens JH; Beijnen JH Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1842-50. PubMed ID: 20533314 [TBL] [Abstract][Full Text] [Related]
7. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Kong SY; Stabler TV; Criscione LG; Elliott AL; Jordan JM; Kraus VB Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970 [TBL] [Abstract][Full Text] [Related]
8. An immunoaffinity liquid chromatography-tandem mass spectrometry assay for the quantitation of matrix metalloproteinase 9 in mouse serum. Ocaña MF; Neubert H Anal Biochem; 2010 Apr; 399(2):202-10. PubMed ID: 20060801 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a method for the detection and confirmation of biomarkers of exposure in human urine by means of restricted access material-liquid chromatography-tandem mass spectrometry. Rodríguez-Gonzalo E; García-Gómez D; Carabias-Martínez R J Chromatogr A; 2010 Jan; 1217(1):40-8. PubMed ID: 19931866 [TBL] [Abstract][Full Text] [Related]
10. Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Berna MJ; Zhen Y; Watson DE; Hale JE; Ackermann BL Anal Chem; 2007 Jun; 79(11):4199-205. PubMed ID: 17447729 [TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples. Zhang Y; Li N; Brown PW; Ozer JS; Lai Y Rapid Commun Mass Spectrom; 2011 Jun; 25(12):1715-24. PubMed ID: 21598331 [TBL] [Abstract][Full Text] [Related]
12. Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis. De Ceuninck F; Sabatini M; Renoux V; de Nanteuil G; Pastoureau P J Rheumatol; 2003 Jul; 30(7):1561-4. PubMed ID: 12858459 [TBL] [Abstract][Full Text] [Related]
13. Increased throughput for low-abundance protein biomarker verification by liquid chromatography/tandem mass spectrometry. Berna M; Ackermann B Anal Chem; 2009 May; 81(10):3950-6. PubMed ID: 19388669 [TBL] [Abstract][Full Text] [Related]
14. Type II collagen markers in osteoarthritis: what do they indicate? Henrotin Y; Addison S; Kraus V; Deberg M Curr Opin Rheumatol; 2007 Sep; 19(5):444-50. PubMed ID: 17762609 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry. Del Mar Ramirez Fernandez M; De Boeck G; Wood M; Lopez-Rivadulla M; Samyn N J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):465-70. PubMed ID: 18922747 [TBL] [Abstract][Full Text] [Related]
16. Quantification of the sulfated cholecystokinin CCK-8 in hamster plasma using immunoprecipitation liquid chromatography-mass spectrometry/mass spectrometry. Young SA; Julka S; Bartley G; Gilbert JR; Wendelburg BM; Hung SC; Anderson WH; Yokoyama WH Anal Chem; 2009 Nov; 81(21):9120-8. PubMed ID: 19799376 [TBL] [Abstract][Full Text] [Related]
17. Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis. Jung M; Christgau S; Lukoschek M; Henriksen D; Richter W Pathobiology; 2004; 71(2):70-6. PubMed ID: 14707441 [TBL] [Abstract][Full Text] [Related]
18. Profiling of endogenous peptides in human synovial fluid by NanoLC-MS: method validation and peptide identification. Kamphorst JJ; van der Heijden R; DeGroot J; Lafeber FP; Reijmers TH; van El B; Tjaden UR; van der Greef J; Hankemeier T J Proteome Res; 2007 Nov; 6(11):4388-96. PubMed ID: 17929855 [TBL] [Abstract][Full Text] [Related]
19. Immuno-capture as ultimate sample cleanup in LC-MS/MS determination of the early stage biomarker ProGRP. Winther B; Nordlund M; Paus E; Reubsaet L; Halvorsen TG J Sep Sci; 2009 Sep; 32(17):2937-43. PubMed ID: 19642102 [TBL] [Abstract][Full Text] [Related]
20. Development of a novel immunoassay for the measurement of type II collagen neoepitope generated by collagenase cleavage. Takahashi T; Naito S; Onoda J; Yamauchi A; Nakamura E; Kishino J; Kawai T; Matsukawa S; Toyosaki-Maeda T; Tanimura M; Fukui N; Numata Y; Yamane S Clin Chim Acta; 2012 Oct; 413(19-20):1591-9. PubMed ID: 22507082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]